Holen Sie sich die Stockscreener-App
3.86
6.88%
-0.285
Handel nachbörslich:
3.95
0.09
+2.33%
Schlusskurs vom Vortag:
$4.145
Offen:
$3.96
24-Stunden-Volumen:
58,746
Relative Volume:
0.18
Marktkapitalisierung:
$6.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.58M
KGV:
-3.3565
EPS:
-1.15
Netto-Cashflow:
$-9.80M
1W Leistung:
-19.08%
1M Leistung:
-33.99%
6M Leistung:
-69.04%
1J Leistung:
-90.90%
1-Tages-Spanne:
$3.83
$4.15
1-Wochen-Bereich:
$3.83
$4.99
52-Wochen-Spanne:
$3.80
$44.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Firmenname
Acurx Pharmaceuticals Inc
Sektor
Branche
Telefon
917-533-1469
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Vergleichen Sie ACXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
3.86 | 6.91M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten
Is Acurx Pharmaceuticals Inc. stock poised for growthWeekly Market Outlook & Target Return Focused Stock Picks - Newser
Acurx Pharmaceuticals Meets Nasdaq Listing Requirements - AInvest
Is Acurx Pharmaceuticals Inc. stock technically oversoldBuy Signal & Weekly Momentum Stock Picks - khodrobank.com
What MACD signals say about Acurx Pharmaceuticals Inc.2025 Trading Recap & High Accuracy Trade Signal Alerts - Newser
Short interest data insights for Acurx Pharmaceuticals Inc.Treasury Yields & Fast Entry Momentum Trade Alerts - Newser
Acurx Pharmaceuticals Reaches Nasdaq Compliance and Maintains Listing. - AInvest
Acurx pharmaceuticals regains compliance with Nasdaq listing rules - Investing.com
Trend analysis for Acurx Pharmaceuticals Inc. this week2025 Price Momentum & Consistent Growth Stock Picks - Newser
Applying sector rotation models to Acurx Pharmaceuticals Inc.July 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Biotech Acurx Pharmaceuticals Secures Future on Nasdaq by Meeting Critical $1 Bid, $2.5M Equity Rules - Stock Titan
Will Acurx Pharmaceuticals Inc. outperform the marketGlobal Markets & Expert Curated Trade Setup Alerts - Newser
Is Acurx Pharmaceuticals Inc. forming a bullish divergenceMarket Growth Report & Verified Entry Point Signals - khodrobank.com
Acurx Pharmaceuticals Inc. stock momentum explainedJuly 2025 Opening Moves & Detailed Earnings Play Strategies - Newser
Automated trading signals detected on Acurx Pharmaceuticals Inc.Portfolio Return Report & Free Technical Confirmation Trade Alerts - Newser
What data driven models say about Acurx Pharmaceuticals Inc.’s future2025 Market WrapUp & Risk Controlled Daily Plans - Newser
How to integrate Acurx Pharmaceuticals Inc. into portfolio analysis tools2025 EndofYear Setup & Community Consensus Stock Picks - Newser
Signal strength of Acurx Pharmaceuticals Inc. stock in tech scannersMarket Volume Report & AI Optimized Trading Strategy Guides - Newser
Real time pattern detection on Acurx Pharmaceuticals Inc. stock2025 Volatility Report & Growth Focused Entry Point Reports - Newser
Analyzing recovery setups for Acurx Pharmaceuticals Inc. investorsPortfolio Update Report & Real-Time Chart Pattern Alerts - Newser
Stock Report: What is Acurx Pharmaceuticals Inc.’s valuation compared to sectorMarket Sentiment Report & Verified Technical Signals - khodrobank.com
What does recent volatility data suggest for Acurx Pharmaceuticals Inc.Volume Spike & Community Trade Idea Sharing - Newser
Published on: 2025-09-02 13:24:12 - Newser
Visual trend scoring systems applied to Acurx Pharmaceuticals Inc.Trade Signal Summary & Daily Chart Pattern Signal Reports - Newser
Using AI based signals to follow Acurx Pharmaceuticals Inc.Layoff News & Daily Growth Stock Investment Tips - Newser
Will Acurx Pharmaceuticals Inc. rebound enough to break evenPortfolio Growth Summary & Smart Money Movement Tracker - Newser
Will Acurx Pharmaceuticals Inc. benefit from macro trendsJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - Newser
Can Acurx Pharmaceuticals Inc. weather a recessionTrade Risk Summary & Daily Oversold Stock Bounce Ideas - khodrobank.com
Using R and stats models for Acurx Pharmaceuticals Inc. forecastingQuarterly Earnings Summary & Precise Buy Zone Identification - Newser
Acurx Pharmaceuticals’ Earnings Call: Optimism Amid Challenges - TipRanks
Technical analysis overview for Acurx Pharmaceuticals Inc. stockWeekly Trade Analysis & Safe Swing Trade Setups - Newser
Published on: 2025-08-31 02:03:09 - Newser
Is Acurx Pharmaceuticals Inc. trading at a discount getLinesFromResByArray error: size == 0 - sisain.net
Can Acurx Pharmaceuticals Inc. rally from current levelsWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - Newser
Published on: 2025-09-01 21:26:06 - Newser
How high can Acurx Pharmaceuticals Inc. stock goWeekly Loss Report & Weekly Watchlist of Top Performers - Newser
What to do if you’re stuck in Acurx Pharmaceuticals Inc.Market Risk Report & Low Risk High Win Rate Stock Picks - Newser
What technical models suggest about Acurx Pharmaceuticals Inc.’s comebackTrend Reversal & Smart Allocation Stock Tips - Newser
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Acurx Pharmaceuticals Inc-Aktie (ACXP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
| LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
| Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
| DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
| DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):